Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis

Matthew T Campbell1, Karen L Hile, Hongji Zhang

  • 1Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Abstract

Insights

Toll-like receptor 4 (TLR4) signaling mediates kidney fibrosis by increasing fibroblast accumulation and collagen deposition. TLR4 deficiency protects against fibrotic renal injury, highlighting its role in kidney disease progression.

Area of Science:

  • Immunology
  • Nephrology
  • Pathology

Background:

  • Toll-like receptor (TLR) signaling is crucial in innate immunity and inflammation.
  • Its role in kidney fibrotic injury was previously unknown.
  • TLR signaling is implicated in inflammatory responses to kidney stimuli.

Purpose of the Study:

  • To investigate the role of Toll-like receptor 4 (TLR4) in mediating renal fibrotic injury.
  • To determine if TLR4 signaling influences fibroblast accumulation and tubulointerstitial fibrosis.

Main Methods:

  • Unilateral ureteral obstruction (UUO) model in wild-type and TLR4-deficient mice.
  • Analysis of TLR4, E-cadherin, alpha smooth muscle actin (α-SMA), fibroblast markers, collagen, and fibrotic markers.
  • Assessment of cytokine (TNF-α, TGF-β1), pSMAD2, and integrin α1 expression.

Main Results:

  • UUO increased TLR4 expression, α-SMA, fibroblast accumulation, collagen deposition, and fibrosis in wild-type mice.
  • TLR4 deficiency significantly reduced obstruction-induced α-SMA, fibroblast accumulation, and fibrosis.
  • TLR4 influenced fibroblast accumulation and fibrosis independently of TNF-α, TGF-β1, or pSMAD2, but involved integrin α1.

Conclusions:

  • TLR4 is a significant mediator of fibrotic renal injury.
  • This study reveals a novel role for TLR4 in renal fibroblast accumulation and tubulointerstitial fibrosis.
  • TLR4 signaling is a potential therapeutic target for fibrotic kidney diseases.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...